A National Call to Action from North Texas
Despite lingering challenges from a post-pandemic bear market and a sharp funding decline last year, Texas biotech companies are finding ways to stay competitive. Momentum is building thanks to new state policies, advances in artificial intelligence, and the potential for federal initiatives such as regulatory reform—factors that are fueling cautious optimism about the sector’s future. That outlook was a key theme at the 2025 iC3 Life Science & Healthcare Innovation Summit, presented by BioNTX on September 16–17 at the Hilton Anatole in Dallas. Industry leaders and experts gathered to share insights on how innovation, collaboration, and policy are shaping the next chapter for biotech in Texas.
A National Call to Action from North Texas